PanTher Therapeutics
Dr. Ting is a translational pancreatic cancer researcher and practicing board certified oncologist at the Massachusetts General Hospital (MGH) Cancer Center. He obtained BS degrees in both biology and chemical engineering from MIT and completed his MD at Harvard Medical School. He performed biomedical research under Dr. Robert Langer working on DNA vaccine delivery systems and then a Howard Hughes Medical Fellowship with Dr. George Daley on stem cell research.
David is now an Assistant Professor at the MGH Cancer Center and Harvard Medical School directing a translational research laboratory focused on pancreatic cancer.
This person is not in the org chart
This person is not in any offices
PanTher Therapeutics
PanTher Therapeutics' mission is to revolutionize cancer care with a proprietary treatment platform designed to enhance therapeutic response with minimal side effects.